Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Merve Bașar

Senior Research Scientist

Sloan Kettering Institute

United States

Research Interests

Explore related searches

Articles (16)

Collaborators (3)

Chao Lu

Assistant Professor

Columbia University

UNITED STATES

Gamze Gokturk Ozcan

Senior Research Scientist

Sloan Kettering Institute

UNITED STATES

Andrew McPherson

Assistant Attending

Sloan Kettering Institute

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Merve Bașar

Research Interests

Explore related searches

Articles (16)

Collaborators (3)

Chao Lu

Gamze Gokturk Ozcan

Andrew McPherson

Make your next move.

Merve Bașar

Research Interests

Explore related searches

Articles (16)

Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non–Muscle-Invasive Bladder Cancer

Occupational Accidents Experienced by Pathology Laboratory Employees in Türkiye

Micropapillary Urothelial Carcinoma: A Review and Update

A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Meme Lezyonlu Kadınlarda Yaşa Göre Radyolojik ve Histopatolojik Korelasyon: Tek Merkezli Bir Çalışma

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

TRANSCRIPTIONAL ANALYSIS OF BLADDER CANCER HISTOLOGIC SUBTYPES REVEALS NOVEL DRUG TARGET HETEROGENEITY

Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications.

CLINICAL, MOLECULAR AND IMMUNOHISTOCHEMICAL PROFILES OF CLEAR CELL ADENOCARCINOMA OF THE URINARY TRACT

A large bleeding mass on the scalp of an elderly male: A quick excision of a delayed case

Final results from a Phase I trial of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guerin (BCG) for patients with BCG-exposed high-grade non-muscle invasive bladder cancer

Lineage plasticity as a determinant of antibody-drug conjugate target expression in urothelial bladder cancer

Urinary cytokine profiles reflect rationale for treatment with gemcitabine and Bacillus Calmette-Guerin (BCG) in BCG-exposed high-risk non-muscle invasive bladder cancer (NMIBC)

Collaborators (3)

Chao Lu

Gamze Gokturk Ozcan

Andrew McPherson

Make your next move.